These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15722315)

  • 1. A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".
    Michaelides M; Holder GE; Webster AR; Hunt DM; Bird AC; Fitzke FW; Mollon JD; Moore AT
    Br J Ophthalmol; 2005 Mar; 89(3):332-9. PubMed ID: 15722315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.
    Michaelides M; Wilkie SE; Jenkins S; Holder GE; Hunt DM; Moore AT; Webster AR
    Ophthalmology; 2005 Aug; 112(8):1442-7. PubMed ID: 15953638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1.
    Michaelides M; Holder GE; Hunt DM; Fitzke FW; Bird AC; Moore AT
    Br J Ophthalmol; 2005 Feb; 89(2):198-206. PubMed ID: 15665353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variation in enhanced S-cone syndrome.
    Audo I; Michaelides M; Robson AG; Hawlina M; Vaclavik V; Sandbach JM; Neveu MM; Hogg CR; Hunt DM; Moore AT; Bird AC; Webster AR; Holder GE
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2082-93. PubMed ID: 18436841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
    Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
    Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
    Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel RPGR ORF15 mutations in X-linked progressive cone-rod dystrophy (XLCORD) families.
    Ebenezer ND; Michaelides M; Jenkins SA; Audo I; Webster AR; Cheetham ME; Stockman A; Maher ER; Ainsworth JR; Yates JR; Bradshaw K; Holder GE; Moore AT; Hardcastle AJ
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1891-8. PubMed ID: 15914600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cone and cone-rod dystrophy segregating in the same pedigree due to the same novel CRX gene mutation.
    Kitiratschky VB; Nagy D; Zabel T; Zrenner E; Wissinger B; Kohl S; Jägle H
    Br J Ophthalmol; 2008 Aug; 92(8):1086-91. PubMed ID: 18653602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral cone dystrophy: a variant of cone dystrophy with predominant dysfunction in the peripheral cone system.
    Kondo M; Miyake Y; Kondo N; Ueno S; Takakuwa H; Terasaki H
    Ophthalmology; 2004 Apr; 111(4):732-9. PubMed ID: 15051206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy.
    Robson AG; Michaelides M; Luong VA; Holder GE; Bird AC; Webster AR; Moore AT; Fitzke FW
    Br J Ophthalmol; 2008 Jan; 92(1):95-102. PubMed ID: 17962389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
    Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
    Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Cone dystrophy with supernormal rod electroretinogram": a comprehensive genotype/phenotype study including fundus autofluorescence and extensive electrophysiology.
    Robson AG; Webster AR; Michaelides M; Downes SM; Cowing JA; Hunt DM; Moore AT; Holder GE
    Retina; 2010 Jan; 30(1):51-62. PubMed ID: 19952985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
    Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
    Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction.
    Michaelides M; Jenkins SA; Brantley MA; Andrews RM; Waseem N; Luong V; Gregory-Evans K; Bhattacharya SS; Fitzke FW; Webster AR
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3085-97. PubMed ID: 16799055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
    Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
    Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals.
    Michaelides M; Johnson S; Simunovic MP; Bradshaw K; Holder G; Mollon JD; Moore AT; Hunt DM
    Eye (Lond); 2005 Jan; 19(1):2-10. PubMed ID: 15094734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotype in a Swedish family with a mutation in the IMPDH1 gene.
    Schatz P; Ponjavic V; Andréasson S; McGee TL; Dryja TP; Abrahamson M
    Ophthalmic Genet; 2005 Sep; 26(3):119-24. PubMed ID: 16272056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations and electrophysiologic findings in RGS9- and R9AP-associated retinal dysfunction (Bradyopsia).
    Michaelides M; Li Z; Rana NA; Richardson EC; Hykin PG; Moore AT; Holder GE; Webster AR
    Ophthalmology; 2010 Jan; 117(1):120-127.e1. PubMed ID: 19818506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.